[Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
D000527:Alprostadil / Q000494:pharmacology / Q000627:therapeutic use*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy* / Q000503:physiopathology; D018849:Controlled Clinical Trials as Topic; D005121:Extremities / Q000098:blood supply; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D016285:Iloprost / Q000494:pharmacology / Q000627:therapeutic use*; D007383:Intermittent Claudication / Q000188:drug therapy / Q000503:physiopathology; D007511:Ischemia / Q000188:drug therapy; D015201:Meta-Analysis as Topic; D008833:Microcirculation / Q000187:drug effects*; D015999:Multivariate Analysis; D016491:Peripheral Vascular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D011379:Prognosis; D012189:Retrospective Studies; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016138:Walking
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D000527:Alprostadil; D016285:Iloprost
Mikrozirkulation bei pAVK wird angekurbelt. Prostaglandin kann den Chirurgen ersparen.